Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Germ Cell Neoplasia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT05076786
What this trial is testing

Chidamide Plus Etoposide and Cisplatin/Carboplatin as First-line Treatment for Extrapulmonary Neuroendocrine Carcinoma

Who this might be right for
Neuroendocrine TumorsNeuroendocrine Carcinoma
Peking Union Medical College Hospital 28
Testing effectiveness (Phase 2)Study completedNCT01288573
What this trial is testing

A Combined Study in Pediatric Cancer Patients for Dose Ranging and Efficacy/Safety of Plerixafor Plus Standard Regimens for Mobilization Versus Standard Regimens Alone

Who this might be right for
Ewing's Sarcoma/Soft Tissue SarcomaNeuroblastomaBrain Tumors
Genzyme, a Sanofi Company 46
Testing effectiveness (Phase 2)Study completedNCT01854554
What this trial is testing

Glioblastoma Multiforme (GBM) Proton vs. Intensity Modulated Radiotherapy (IMRT)

Who this might be right for
Brain Cancer
M.D. Anderson Cancer Center 90
Not applicableStudy completedNCT01489423
What this trial is testing

Tissue and Blood Biomarkers From Patients With Stage III or Stage IV Melanoma Treated With Ipilimumab With or Without Sargramostim

Who this might be right for
Melanoma (Skin)
Eastern Cooperative Oncology Group 270
Not applicableStudy completedNCT06451042
What this trial is testing

FET-PET/MRI Based Treatment Planning for Glioblastoma Multiforme in Post-Surgical Patients (FET-TREAT)

Who this might be right for
Glioblastoma Multiforme
Sunnybrook Health Sciences Centre 11
Early research (Phase 1)Study completedNCT00399113
What this trial is testing

Safety Study of 188Re-PTI-6D2 in Patients With Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Pain Therapeutics 12
Early research (Phase 1)Looking for participantsNCT05366179
What this trial is testing

Autologous CAR-T Cells Targeting B7-H3 in Recurrent or Refractory GBM CAR.B7-H3Tc

Who this might be right for
Glioblastoma Multiforme
UNC Lineberger Comprehensive Cancer Center 36
Large-scale testing (Phase 3)Study completedNCT01868269
What this trial is testing

Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)

Who this might be right for
Opsoclonus Myoclonus SyndromeNeuroblastoma
Institut Curie 102
Early research (Phase 1)Looking for participantsNCT06428045
What this trial is testing

STARLITE for Unresectable High-Grade Gliomas

Who this might be right for
High Grade Glioma
University of Miami 24
Not applicableStudy completedNCT03481231
What this trial is testing

In Situ Immune Parameters and Their Prognostic Role on the Survival of Patients With Glioblastoma

Who this might be right for
Glioblastoma
Centre Georges Francois Leclerc 160
Early research (Phase 1)UnknownNCT04142931
What this trial is testing

Sequentional Immuno Apheresis Plasma Volume Escalation Cohort Study of Reduction of Soluble Tumor Necrosis Factor Receptors 1 and 2 (sTNFR1/2) With or Without Nivolumab in Patients With Inoperable or Metastatic Solid Tumors

Who this might be right for
Stage IV Non-small Cell Lung CancerStage IV MelanomaTriple Negative Breast Cancer+1 more
Dr. Ronnie Shapira 30
Testing effectiveness (Phase 2)UnknownNCT00637637
What this trial is testing

External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases

Who this might be right for
Cancer
Oncology Institute of Southern Switzerland 60
Large-scale testing (Phase 3)Active Not RecruitingNCT04211337
What this trial is testing

Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer

Who this might be right for
Medullary Thyroid Cancer
Loxo Oncology, Inc. 291
Not applicableNot Yet RecruitingNCT06869577
What this trial is testing

A Supportive Group Intervention for Caregivers to Patients Diagnosed With a Glioblastoma

Who this might be right for
CaregiverGlioblastoma Multiform (Grade IV Astrocytoma)
Rigshospitalet, Denmark 24
Large-scale testing (Phase 3)Study completedNCT00003375
What this trial is testing

Observation or Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Low-Grade Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Radiation Therapy Oncology Group 370
Testing effectiveness (Phase 2)UnknownNCT00360945
What this trial is testing

Cisplatin and Temozolomide in Treating Young Patients With Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Children's Cancer and Leukaemia Group 87
Not applicableNot Yet RecruitingNCT07114172
What this trial is testing

Study of Melanoma-Resistant PET Monitoring Based on Key Rate-limiting Enzymes for Fatty Acid Metabolism in Healthy Volunteers

Who this might be right for
Melanoma (Skin Cancer)Health VolunteersPET / CT
Xijing Hospital 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT04385277
What this trial is testing

Treatment With Dinutuximab, Sargramostim (GM-CSF), and Isotretinoin in Combination With Irinotecan and Temozolomide After Intensive Therapy for People With High-Risk Neuroblastoma (NBL)

Who this might be right for
Ganglioneuroblastoma, NodularNeuroblastoma
Children's Oncology Group 41
Testing effectiveness (Phase 2)WithdrawnNCT02862145
What this trial is testing

Pharmacodynamics Study of MRX34, MicroRNA Liposomal Injection in Melanoma Patients With Biopsy Accessible Lesions

Who this might be right for
Melanoma
Mirna Therapeutics, Inc.
Post-approval studies (Phase 4)WithdrawnNCT02415257
What this trial is testing

Gentamicin Treatment Prior to Schwannoma Surgery - No Residual Function

Who this might be right for
Vestibular Schwannoma
Lund University
Next Page